Safety of endoscopic sphincterotomy in patients undergoing antithrombotic treatment: a retrospective study.
antithrombotic treatment
endoscopic retrograde cholangiopancreatography
endoscopic sphincterotomy
Journal
Therapeutic advances in gastrointestinal endoscopy
ISSN: 2631-7745
Titre abrégé: Ther Adv Gastrointest Endosc
Pays: United States
ID NLM: 101741179
Informations de publication
Date de publication:
Historique:
received:
07
02
2019
accepted:
05
04
2019
entrez:
14
6
2019
pubmed:
14
6
2019
medline:
14
6
2019
Statut:
epublish
Résumé
This study investigated the safety of endoscopic sphincterotomy in patients undergoing antithrombotic treatment. From January 2014 to December 2016, a single-center retrospective study was conducted. Of the 80 patients with naïve papilla receiving antithrombotic treatment who underwent endoscopic sphincterotomy, 76 patients were retrospectively analyzed. We divided the participants into two groups as follows: 45 patients who discontinued antithrombotic treatment (discontinuation group) and 31 patients who continued antithrombotic treatment (continuation group). We evaluated the safety of endoscopic sphincterotomy in patients with naïve papilla who received antithrombotic treatment. The percentage of patients requiring emergency endoscopic retrograde cholangiopancreatography in the continuation group was significantly higher than that in the discontinuation group (55% vs 11%; Endoscopic sphincterotomy in patients undergoing antithrombotic treatment may be safe if the guidelines for gastroenterological endoscopy in patients undergoing antithrombotic treatment are followed.
Sections du résumé
BACKGROUND
BACKGROUND
This study investigated the safety of endoscopic sphincterotomy in patients undergoing antithrombotic treatment.
METHODS
METHODS
From January 2014 to December 2016, a single-center retrospective study was conducted. Of the 80 patients with naïve papilla receiving antithrombotic treatment who underwent endoscopic sphincterotomy, 76 patients were retrospectively analyzed. We divided the participants into two groups as follows: 45 patients who discontinued antithrombotic treatment (discontinuation group) and 31 patients who continued antithrombotic treatment (continuation group). We evaluated the safety of endoscopic sphincterotomy in patients with naïve papilla who received antithrombotic treatment.
RESULTS
RESULTS
The percentage of patients requiring emergency endoscopic retrograde cholangiopancreatography in the continuation group was significantly higher than that in the discontinuation group (55% vs 11%;
CONCLUSIONS
CONCLUSIONS
Endoscopic sphincterotomy in patients undergoing antithrombotic treatment may be safe if the guidelines for gastroenterological endoscopy in patients undergoing antithrombotic treatment are followed.
Identifiants
pubmed: 31192316
doi: 10.1177/2631774519846327
pii: 10.1177_2631774519846327
pmc: PMC6537482
doi:
Types de publication
Journal Article
Langues
eng
Pagination
2631774519846327Déclaration de conflit d'intérêts
Conflict of interest statement: The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Références
Arch Neurol. 2005 Aug;62(8):1217-20
pubmed: 16087761
J Hepatobiliary Pancreat Surg. 2007;14(1):1-10
pubmed: 17252291
Aliment Pharmacol Ther. 2007 Mar 1;25(5):579-84
pubmed: 17305758
J Clin Epidemiol. 2008 Dec;61(12):1234-40
pubmed: 18619805
Gastrointest Endosc. 1991 May-Jun;37(3):383-93
pubmed: 2070995
Dig Endosc. 2014 Jan;26(1):1-14
pubmed: 24215155
Endoscopy. 2015 Nov;47(11):997-1004
pubmed: 26126160
Gastrointest Endosc. 2016 Jan;83(1):3-16
pubmed: 26621548
Endoscopy. 2016 Apr;48(4):c1
pubmed: 28114689
J Gastroenterol. 2017 Dec;52(12):1258-1265
pubmed: 28478523
Gut. 2018 Oct;67(10):1805-1812
pubmed: 28874418
Am J Surg. 1995 Oct;170(4):356-60
pubmed: 7573728